املؤمتر الدويل الرابع لجمعية امراض الدم األردنية

The 4 th International Conference of the Jordanian Society of Hematology املؤمتر الدويل الرابع لجمعية امراض الدم األردنية Jordanian Society of Hematology February 10 th - 12 th, 2016 Le Royal Hotel Amman, Jordan Organized by Jordanian Society of Hematology

4 The 4 th International Conference of the Jordanian Society of Hematology Topics Acute Leukemias, Chronic Leukemias, Lymphoma, Multiple Myeloma, Myelodysplastic syndrome, Benign Hematology, Bleeding and thrombotic disorders, Supportive Care Committees Dr. Salah Abbasi President of Conference President of JSH Dr. Abdullah Awidi Abbadi Vice President of JSH/ Conference Dr. Adnan Abu Rajab Treasurer Dr. Ahmad Telfah Chairman of Executive Committee Dr. Khalifa Omari Chairman of Preparatory Committee Dr. Ghadeer Abdeen Chairman of Scientific Committee Dr. Ahmad Magableh Secretary General of JSH Dr. Basem Kiswani Media Committee A Scientific Exhibition will be running throughout the days of the conference

The 4 th International Conference of the Jordanian Society of Hematology 5 Day I February 10 th, 2016 16.00-19.00 Registration Session I Stem Cell Therapy /MDS/ Anemia 16.00-18.00 Moderators: 1) Mohammed Salameh, M.D 2) Nabil Alloush, M.D 16.00-16.25 16.25-16.50 16.50-17.15 Stem Cell Therapy: Current Status Abdallah Abbadi, M.D Anemia in Cancer Patients Hikmat Abdel Razek, M.D MDS/ Anemia overlap Ghulam Mufti, M.D 17.15-17.30 17.30-18.00

6 The 4 th International Conference of the Jordanian Society of Hematology Session II Novartis Symposium/CML (18.00-20.00) Moderators: Faek Madant, M.D 18.00-20.00 CML Update Giueseppe Saglio, M.D 20.00 Day II February 11 th, 2016 Session I Acute Leukemia (08.30-11.00) Moderators:1) Sana Sukon, M.D 2) Eyad Arafat, M.D 3) Lina Merie, M.D 08.30-08.55 Current Status And future Options In The Diagnostic And Treatment of Adult Acute lymphoblastic leukemia Including New Immunotherapy Approaches Dieter Hoelzer, M.D 08.55-09.20 Acute Myeloid Leukemia: The Impact of Age Thomas Büchner, M.D 09.20-09.45 Therapy of high-grade T- and B-lymphoblastic lymphoma and Burkitt lymphoma Dieter Hoelzer, M.D

The 4 th International Conference of the Jordanian Society of Hematology 7 09.45-10.10 10.10-10.30 10.30-11.00 Acute Myeloid Leukemia: The Impact of Treatment Intensity Thomas Büchner, M.D Discussion Coffee Break Session II Bone Marrow Transplant /MDS (11.00-13.00) Moderators:1) Khalifeh Omari, M.D 2) Omar Rawi, M.D 11.00-11.25 Epidemiology, Diagnostics (molecular) And Treatment of MDS Theo de Witte, M.D 11.25-11.50 Transplant In Hodgkin disease Fawzi Abdelrahman, M.D 11.50-12.15 Algorithm of Treatment of Aplastic Anemia: An Update Ayad Ahmed Hussein, M.D 12.15-12.40 The Role of Allogeneic Stem cell Transplantation In MDS Theo de Witte, M.D 12.40-13.00 Session III Hikma Symposium / CML Update (13.00-15.00) Chairman: Abdullah Abbadi, M.D

8 The 4 th International Conference of the Jordanian Society of Hematology 13.00-14.00 14.00-15.00 1- How I treat CML in 2016 Carlo Gambacorti Passerini, M.D 2- Cemivil in CML Treatment in Jordan: Real World Evidence Neyla G. Darwaza, M.D 15.00-16.00 Session IV Bleeding Disorders/ ITP (15.30-17.30) Moderators: 1) Mousa Barqawi, M.D 2) Nazzal Bsoul, M.D 15.30-15.55 15.55-16.20 16.20-16.45 16.45-17.00 17.00-17.30 Current and Future Approaches in Glanzmann s thrombasthenia Roseline d OIRON, M.D The Biology of Thrombopoietin and its Clinical Use in Hematology David Kuter, M.D Rare Bleeding Disorders Roseline d OIRON, M.D Discussion Coffee Break

The 4 th International Conference of the Jordanian Society of Hematology 9 Session V Novartis Symposium Myeloproliferative Disorders (18.00-20.00) Moderators: Marwan Akasheh, M.D 18.00-20.00 20.00 Myelofibrosis Andreas Reiter, M.D Dinner Day III February 12 th, 2016 Session I Multiple Myeloma/ Thrombosis (09.00-11.15) Moderators: 1) Ahmad Telfah, M.D 2) Kamal Al Rabee, M.D 09.00-09.25 09.25-10.10 First Line Therapy in Multiple Myeloma In Non-Transplant Candidate Thierry Facon, M.D Treatment of VTE with Direct Oral Anticoagulation Harry R. Büller, M.D 10.10-10.30

10 The 4 th International Conference of the Jordanian Society of Hematology 10.30-10.55 10.55-11.15 11.15-12.30 Treatment of Relapsed Refractory Multiple Myeloma Thierry Facon, M.D Discussion Friday Prayer Session II Symposium/ Roche (12.30-14.30) Moderators: Mohammed Dowairy, M.D 12.30-13.30 13.30-15.30 Surviving lymphoma :The dark side of Success Alaa Addasi, M.D Lunch Session III Lymphoma (15.30-17.00) Moderators: 1) Ahmad Othman, M.D 2) Mohammed Bishtawi, M.D 15.30-15.55 15.55-16.20 16.20-16.30 Burkitts lymphoma :Un Update Waleed Rashid, M.D Pathological classification of Non Hodgkin Lymphoma Nidal Masri, M.D Discussion

The 4 th International Conference of the Jordanian Society of Hematology 11 16.30-17.00 Coffee Break Session IV Benign Hematology (17.00-18.30) Moderators: 1) Ahmad Maqableh, M.D 2) Basem Kiswani, M.D 17.00-17.25 17.25-18.25 18.25-18.45 18.45-18.55 Cerebrovascular Problems in Hemoglobinopathies David Rees, M.D The Role of Revolade in the Management of ITP Adrian Newland, M.D Future Trends in Treatment of Hemoglobinopathies David Rees, M.D Discussion Moderators: Alaa Addasi, M.D Session V Immune Therapy- MSD Symposium (19.00-21.00) 19.00-20.00 20.00 Immunotherapy in Hematological Malignancies Mohammed Salameh, M.D Dinner

12 The 4 th International Conference of the Jordanian Society of Hematology Local & Regional Papers 1. Iron Deficiency in Yemeni Children with Sickle Cell Anemia/ Saeed Thabet Nasher, M.D/ Yemen 2. Characteristics of Patients with Hyperleukocytosis in Pediatrics Acute Lymphoblastic Leukemia (A.L.L.) at King Faisal Hospital and Research Center, Riyadh, Saudi Arabia/ Suleimman Al-Swedan, M.D et al. / KSA 3. Prospective study to determine the effectiveness of N-plate (Romiplostim) on ITP patients/ Manal Elhabbash, M.D et al. 4. Aberrant Antigen Expression in Jordanian Patients with Acute Leukemia: Our Experience at King Hussein Medical Center / Nabeeha Abbasi, M.D et al./khmc 5. Primary breast lymphoma case report a rare entity and literature review/ Arwa M. NADI, M,D and Ahmad Y. Magableh M.D/ Department of pathology and Department of Hemato-Oncology, Al-Bashir Hospital, Amman-Jordan